In vitro efficacy of RiaSTAP after rapid reconstitution

Journal of Surgical Research

Volumn 190, Issue 2, 2014, Pages 655-661

  Karri, Jay V ^a   Cardenas, Jessica C ^a   Johansson, Pär I ^a,c   Matijevic, Nena ^a   Cotton, Bryan A ^a,c   Wade, Charles E ^a,b   Holcomb, John B ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cryoprecipitate; Fibrinogen; Resuscitation; RiaSTAP; Trauma

Indexed keywords

FIBRINOGEN CONCENTRATE; PROTOCOL RECONSTITUTED FIBRINOGEN CONCENTRATE; RAPID RECONSTITUTED FIBRINOGEN CONCENTRATE; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; CLAUSS ASSAY; CONTROLLED STUDY; CRYOPRECIPITATE; DRUG EFFICACY; HEMATOLOGICAL PROCEDURE; HUMAN; MAXIMUM AMPLITUDE; PRIORITY JOURNAL; THROMBOELASTOGRAPHY;

CRYOPRECIPITATE; FIBRINOGEN; RESUSCITATION; RIASTAP; TRAUMA;

FACTOR VIII; FIBRINOGEN; HEMOSTASIS; HEMOSTATIC TECHNIQUES; HUMANS; SOLUBILITY;

EID: 84904255501     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.01.055     Document Type: Article

References (25)

1. J.R. Hess, K. Brohi, and R.P. Dutton et al. The coagulopathy of trauma: a review of mechanisms J Trauma 65 2008 748
2. S.T. Hiippala, G.J. Myllyla, and E.M. Vahtera Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates Anesth Analg 81 1995 360
3. B. Sorensen, O.H. Larsen, C.J. Rea, M. Tang, J.H. Foley, and C. Fenger-Eriksen Fibrinogen as a hemostatic agent Semin Thromb Hemost 38 2012 268
4. B. Sorensen, M. Tang, O.H. Larsen, P.N. Laursen, C. Fenger-Eriksen, and C.J. Rea The role of fibrinogen: a new paradigm in the treatment of coagulopathic bleeding Thromb Res 128 Suppl 1 2011 S13
5. J.B. Holcomb Traditional transfusion practices are changing Crit Care 14 2010 162
6. C. Rourke, N. Curry, and S. Khan et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes J Thromb Haemost 10 2012 1342
7. H.K. Stinger, P.C. Spinella, and J.G. Perkins et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital J Trauma 64 2008 S79 discussion S85
8. J.B. Holcomb, E.E. Fox, and X. Zhang et al. Cryoprecipitate use in the Prospective Observational Multicenter Major Trauma Transfusion study (PROMMTT) J Trauma Acute Care Surg 75 2013 S31
9. RiaSTAP US Package insert. Accessed 22 November 2013. http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm094006.pdf.
10. M. Franchini, and G. Lippi Fibrinogen replacement therapy: a critical review of the literature Blood Transfus 10 2012 23
11. R. Rossaint, B. Bouillon, and V. Cerny et al. Management of bleeding following major trauma: an updated European guideline Crit Care 14 2010 R52
12. M.A. Meyer, and P.I. Johansson Fibrinogen concentrates in bleeding trauma patients Int Soc Blood Trans 7 2012 177
13. K.A. Tanaka, K. Egan, and F. Szlam et al. Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion Transfusion 54 2014 109
14. RiaSTAP vs. Conventional transfusion in patients having heart valve surgery (RiaCT). Accessed 22 November 2013. http://www.clinicaltrials.gov/ct2/ show/NCT01283321?term=01283321&rank=12013.
15. C. Fenger-Eriksen, T.M. Jensen, and B.S. Kristensen et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial J Thromb Haemost 7 2009 795
16. J.L. Callum, and S. Rizoli Assessment and management of massive bleeding: coagulation assessment, pharmacologic strategies, and transfusion management Hematology Am Soc Hematol Educ Program 2012 2012 522
17. C. Zentai, O. Grottke, D.R. Spahn, and R. Rossaint Nonsurgical techniques to control massive bleeding Anesthesiol Clin 31 2013 41
18. K.S. Birdi Self-assembly monolayer structures of lipids and macromolecules at interfaces 1999 Kluwer Academic/Plenum Publishers New York
19. J.F. Zayas Functionality of proteins in food 1997 Springer New York
20. A. Cooper, and M.W. Kennedy Biofoams and natural protein surfactants Biophys Chem 151 2010 96
21. M. Hoffman, and P. Jenner Variability in the fibrinogen and von Willebrand factor content of cryoprecipitate. Implications for reducing donor exposure Am J Clin Pathol 93 1990 694
22. J.L. Callum, K. Karkouti, and Y. Lin Cryoprecipitate: the current state of knowledge Transfus Med Rev 23 2009 177
23. C. Fenger-Eriksen, K. Christiansen, J. Laurie, B. Sorensen, and C. Rea Fibrinogen concentrate and cryoprecipitate but not fresh frozen plasma correct low fibrinogen concentrations following in vitro haemodilution Thromb Res 131 2013 e210
24. A. Theodoulou, J. Berryman, A. Nathwani, and M. Scully Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia Transfus Apher Sci 46 2012 159
25. S. Ahmed, C. Harrity, and S. Johnson et al. The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage - an observational study Transfus Med 22 2012 344